Cirrus expands US plant by 30,000 sq ft for aircraft manufacturing

US-based Cirrus has announced a multi-million-dollar, 30,000-square-foot expansion at its Grand Forks facility to meet growing demand for its products across its portfolio.

Cirrus, a global leader in personal aviation, recently opened its expanded manufacturing facility in Grand Forks, North Dakota. This investment advances Cirrus’ mission to ensure manufacturing excellence, safety, quality, and long-term growth.

“This expansion reflects our continued investment in our people, our products, and the Grand Forks community,” said Zean Nielsen, Chief Executive Officer at Cirrus. “By adding more than 30,000 square feet, creating new jobs, and enhancing our workplace for our team members, we’re positioning Cirrus for continued growth.”

“The strong partnerships we’ve built with the City of Grand Forks, the State of North Dakota, the Bank of North Dakota, and the University of North Dakota have given us the confidence to continue investing here, including making Grand Forks the location where we will manufacture composites for the new TRAC10 flight training aircraft.”

Cirrus expands to deliver

Founded in 1984, Cirrus is the recognized global leader in personal aviation and the maker of the best-selling SR Series piston aircraft and the Vision Jet—the world’s first single-engine Personal Jet and the recipient of the Robert J. Collier Trophy.

Since its inception, the company has redefined aviation performance, comfort, and safety with innovations like the Cirrus Airframe Parachute System (CAPS)—the first FAA-certified whole-airframe parachute safety system included as standard equipment on an aircraft, according to a news release.

“To date, worldwide flight time on Cirrus aircraft is over 19 million hours, and over 300 people have returned home safely to their families as a result of the inclusion of CAPS as a standard feature on all Cirrus aircraft,” added Cirrus.

“The company has seven locations in the United States, including Duluth, Minnesota; Grand Forks, North Dakota; Greater Dallas, Texas; Greater Phoenix, Arizona; Greater Orlando, Florida; Knoxville, Tennessee, and Benton Harbor, Michigan.”

The company emphasized the importance of the Grand Forks, North Dakota, location as central to its manufacturing power. Home to about 500 employees, with approximately 80% of them dedicated to direct manufacturing operations, the company called the recent expansion “a significant milestone.” Built to meet current and future production rates, “the expanded facility enables an optimized production layout that streamlines the movement of composite parts throughout the manufacturing process,” according to a news release.

“Grand Forks has played an essential role in Cirrus’ growth and manufacturing strategy for decades,” said Pat Waddick, President of Innovation and Operations at Cirrus in a news release. “Our success starts with our people and our supportive community. This investment allows us to create an even better environment for our team while expanding the capacity and capabilities needed to support our continued growth.”

This growth reflects strong demand and Cirrus’ commitment to both innovation and its employees. The company also highlighted its close partnership with the Grand Forks community, noting that local contributions to the expansion demonstrate a shared commitment to advancing economic growth and manufacturing in the region.

The expanded facility officially opens on August 14. It strengthens Cirrus’ manufacturing network, ensuring the company is well-positioned to meet customer demand while continuing to deliver the quality, innovation, and craftsmanship that define every Cirrus aircraft.

Source link

Durkin: North American Trade Is Critical to U.S. Manufacturing

America’s relationship with Mexico and Canada is the most complementary and symbiotic set of trade relationships the United States has, NAM Vice President of International Policy Andrea Durkin said on Grant Thornton’s DC Dispatch podcast recently.

• Durkin’s comments come as U.S. and Canadian trade leaders meet to resolve differences ahead of proposed U.S. tariffs on Canada scheduled to take effect on Aug. 19.

The case for USMCA: “We export one-third of all U.S. manufactured goods to Canada and Mexico,” Durkin told Grant Thornton’s David Sites and Colin Wilhelm. “That is more than to the next nine U.S. manufacturing export partners combined.”

• “And since implementation of USMCA, 15 of 18 manufacturing sub-sectors have increased their exports to Canada and Mexico, and they’re growing faster than to other markets.”

A symbiotic relationship: Many companies straddle these borders and benefit hugely from drawing resources from—and selling goods to—all of North America. “Half of what we’re buying from Canada and nearly 70% of what we buy from Mexico is trade within a single corporate parent,” Durkin pointed out. “It is truly regionalized co-production.”

• Durkin emphasized that America’s trade relationship with Mexico and Canada helps it compete with China, and that the administration must balance its desire to onshore as much production as possible with keeping that regional partnership strong.

The review process explained: As a key champion of the USMCA when it was originally passed, the NAM urged policymakers to renew and modernize the agreement during its scheduled review in July. The Trump administration decided not to pursue a 16-year renewal this year, but as Durkin told the podcast hosts, that was no catastrophe.

• The agreement will stay in force for another decade, and the three countries will continue to conduct annual reviews (CNBC).

Priorities for cooperation: Durkin laid out a few priorities for policymakers as they consider the ongoing maintenance of the agreement.

• Strengthen implementation and coordination: “With the volume of trade and breadth of this agreement, there will always be implementation issues on any given day,” she said, noting the three countries should continually look for ways to improve coordination, make trade at the border more fluid and manage risks more effectively. “That can always be improved and should be regularly discussed.”
• Build on the agreement: The countries should pursue additional cooperation on customs facilitation, energy, AI policy or critical minerals policy, without necessarily reopening the USMCA itself, Durkin continued. 
• Address changes carefully: They should also continue discussions on consequential issues that could affect how companies use the agreement, including potential changes to rules of origin. 

The geopolitical angle: Durkin also highlighted the administration’s push to compete with China.

• Emphasizing that competition with China will continue to drive U.S. investment in the “technological race in advanced manufacturing,” Durkin pointed out the importance of U.S. policies aimed at helping manufacturers “retain competitiveness in advanced manufacturing” and “leapfrog” in sectors where it needs to maintain preeminence.
• At the same time, she stressed the need to reduce overreliance on single markets and supply chain “choke points,” arguing that manufacturers’ global footprint and diversification with U.S. allies are a “source of resilience.”

The bottom line: Durkin urged policymakers to work closely with manufacturers as they consider changes to the agreement—particularly aground rules of origin, where adjustments can ripple across supply chains and affect costs and competitiveness across the sector.

• “Our advice to the government is: Please work with us,” she said. “We will be happy to test-proof some innovative ideas around rules of origin.”
• Durkin said manufacturers can help policymakers determine which parts of the production process are most important to retain in the United States—and where the region can benefit from integrated North American supply chains, including access to raw materials that are not available domestically.

Source link

XTEND Highlights U.S. Drone Manufacturing Expansion as New Tariffs Strengthen Case for Domestic NDAA-Compliant Supply Chain

~ New Tariffs of Up to 100% on Imported Drones Underscore the Case for the Domestic, NDAA-Compliant Manufacturing Base XTEND Has Been Building ~

~ Company’s Growing Tampa-Based XFAB Facility and U.S. Manufacturing Relationships Support XTEND’s Plans to Scale Production as America Reduces Reliance on Foreign-Made Drone Technology ~

TAMPA, Fla., Aug. 14, 2026 (GLOBE NEWSWIRE) —

JFB Construction Holdings (Nasdaq: JFB) announced today that XTEND, a leader in AI-powered autonomy and software-defined robotics, is positioned to support America’s newly announced drive to strengthen its domestic drone industrial base. President Trump this week signed a proclamation imposing tariffs of up to 100% on imported drones and certain drone components, citing national security risks tied to foreign-made, and in particular Chinese-made, unmanned aircraft technology and the need to strengthen the U.S. drone industrial base. Under the proclamation, drones weighing more than 25 kilograms or equipped with thermal imaging, along with their docking stations and critical components, are subject to a 100% tariff, while smaller drones lacking security-sensitive features and other drone components face a 25% tariff, with most provisions taking effect within 21 days of signing.

As the United States moves decisively to strengthen its domestic drone industrial base and reduce dependence on Chinese technology, XTEND finds itself exactly where it was built to be.

XTEND has been developing and supplying NDAA-compliant drone technology and robotic systems to the U.S. Department of War (“DOW”), winning U.S. defense programs and investing in the American manufacturing infrastructure needed to produce them at scale in the United States.

XTEND’s growing U.S. manufacturing facility, XFAB, in Tampa, Florida, which XTEND is continuing to develop and expand, was built around this exact vision, which is directly aligned with the objectives of the new proclamation: bring critical drone technology, components and manufacturing to the United States and create a secure American alternative to foreign-controlled supply chains. The Tampa facility is the U.S. anchor of XTEND’s global XFAB manufacturing network, which combines localized regional production with centralized software innovation through its proprietary XTEND Operating System (XOS) across facilities in the United States, the United Kingdom, Singapore, Israel, and Latvia. Earlier this month, XTEND announced that it had produced seven robotic platforms across its five global XFAB facilities in a single week, all powered by XOS. As XTEND continues to build out its U.S. production capacity, it also works with U.S.-based manufacturers to support increased production. XTEND believes it brings not only its technology, but also its proven XFAB model for building a network of American manufacturing at scale.

Beyond defense, XTEND is also expanding into the private security market, and expects its ability to deliver NDAA-compliant drones manufactured in the United States to be a competitive advantage there as well, as private security customers increasingly prioritize secure, domestically manufactured systems.

Today, that vision has become a national priority.

XTEND wasn’t built in response to this moment. XTEND was built for it.

“We made the bet that America would need a homegrown, NDAA-compliant alternative to Chinese drone technology, and we are building XFAB, our people and our supply chain around that bet,” said Aviv Shapira, Chief Executive Officer of XTEND. “These tariffs validate what our defense customers have known for years: security and resilience start with who builds your technology and where. We’re not reacting to this moment; we’ve been preparing for it since day one, and we’re building the capacity to scale.”

To sign up to receive press releases in real time, please visit ir.xtend.me.

As announced on February 17, 2026, JFB Construction Holdings (Nasdaq: JFB) and XTEND entered into a definitive agreement to combine in an all-stock transaction. The business combination is further supported by strategic investments from Eric Trump, Unusual Machines, American Ventures, LLC, Protego Ventures, and Aliya Capital. The U.S. Securities and Exchange Commission declared the registration statement on Form S-4 relating to the transaction effective on August 11, 2026, clearing the way toward an anticipated closing on September 1, 2026, subject to customary closing conditions. Upon closing, the combined company will be renamed XTEND AI Robotics, Inc., a U.S. public company incorporated in Delaware, and is expected to trade on the New York Stock Exchange under the ticker symbol “XTND.” The closing will complete XTEND’s transition to a U.S.-domiciled public company, aligning its corporate structure with its growing American manufacturing footprint.

About XTEND

XTEND is a leader in software systems and artificial intelligence-powered robotics, deployed in high-threat, complex operational environments where human exposure carries significant risk. Powered by its proprietary XTEND Operating System (XOS), XTEND’s integrated software and advanced robotic hardware solutions are designed to provide autonomy at the edge. Operating across defense, law enforcement, and private security missions through a platform of robots, drones, and robotic subsystems, XTEND’s open architecture platform facilitates scalability across partners and third-party applications. With over 12,500 systems deployed in over 30 countries, XTEND’s solutions have been validated in five combat zones and operationally deployed by national defense, special-mission units, and security organizations across the globe. Founded in Tel Aviv, Israel, and headquartered in Tampa, Florida, XTEND delivers NDAA-compliant solutions through a global network of regional XFAB manufacturing facilities located in the U.S., the U.K., Singapore, Israel, and Latvia. XTEND has previously announced a proposed business combination with JFB Construction Holdings (Nasdaq: JFB); upon closing, the combined company will be renamed XTEND AI Robotics, Inc., a U.S. public company incorporated in Delaware. For more information, visit

www.xtend.me

.

About JFB Construction Holdings

JFB Construction Holdings (Nasdaq: JFB) is a real estate development and construction company that has provided general contracting and construction management services in 36 U.S. states. For more information, visit the company’s SEC filings at

www.sec.gov

.

Forward-Looking Statements

This communication contains, and oral statements made from time to time by our representatives may contain, forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933, as amended (the “Securities Act”), and Section 21E of the Securities Exchange Act of 1934, as amended. These forward-looking statements generally include statements regarding the anticipated impact of recently announced U.S. tariffs on imported drones and drone components, XTEND’s ability to scale U.S. manufacturing at its XFAB facility, XTEND’s relationships with U.S.-based manufacturers, its ability to build a network of U.S. manufacturing at scale, and their anticipated contribution to increased production, XTEND’s expansion into the private security market and the anticipated benefits of U.S.-based, NDAA-compliant manufacturing in that market, the potential transaction between XTEND Reality Expansion Ltd. (“XTEND”) and JFB Construction Holdings (“JFB”), including statements regarding the expected impacts and benefits of the potential transaction, the timing of the transaction closing, and strategic initiatives for XTEND AI Robotics, Inc. (“NewCo”) following the closing. All statements other than statements of historical facts contained in this communication may be forward-looking statements. In some cases, you can identify forward-looking statements by terms such as “may,” “will,” “outlook,” “should,” “expects,” “plans,” “anticipates,” “could,” “intends,” “targets,” “projects,” “contemplates,” “believes,” “estimates,” “predicts,” “potential” or “continue” or the negative of these terms or other similar expressions.

The forward-looking statements in this communication are only predictions. XTEND’s and JFB’s management have based these forward-looking statements largely on their current expectations and projections about future events and financial trends that management believes may affect its business, financial condition and results of operations. These statements are neither promises nor guarantees and involve known and unknown risks, uncertainties and other important factors that may cause actual results, performance or achievements to be materially different from what is expressed or implied by the forward-looking statements, including, but not limited to: the ultimate scope, duration, and implementation of recently announced tariffs on imported drones and components, and their impact on XTEND’s costs, competitive position, and customers; the proposed transaction with JFB may not be consummated, or may not close on the anticipated timeline; there may be difficulties integrating the two companies and realizing the expected benefits of the transaction; XTEND’s ability to complete the continued development of, and scale U.S.-based manufacturing at XFAB to meet increased demand; XTEND’s ability to maintain and expand its relationships with U.S.-based manufacturers, to build a network of U.S.-based manufacturing at scale, and to realize the expected benefits of these relationships; XTEND’s ability to successfully expand into the private security market; XTEND’s dependence on a limited number of defense and governmental security customers for a substantial portion of its business; significant delays or reductions in appropriations, XTEND’s programs and certain government funding and programs more broadly, including as a result of a prolonged continuing resolution and/or government shutdown, and/or related to the global security environment or other global events; increased competition within XTEND’s and JFB’s markets; changes in procurement and other U.S. and foreign laws, including changes through executive orders and tariff actions, contract terms and practices applicable to our industry; disruptions in supply chains and the cost of components and materials; cyber and other security threats or disruptions faced by XTEND and JFB, its customers or its suppliers and other partners; and XTEND’s ability to innovate, develop new products and technologies, and maintain technologies to meet the needs of XTEND’s customers. In addition, a number of important factors could cause JFB’s, XTEND’s or NewCo’s actual future results and other future circumstances to differ materially from those expressed in any forward-looking statements, including but not limited to those important factors discussed in the section entitled “Risk Factors” in the registration statement on Form S-4 filed by JFB and NewCo, as any such factors may be updated from time to time in other filings with the Securities and Exchange Commission (the “SEC”), which are available on the SEC’s website at

https://www.sec.gov

and on XTEND’s investor relations site at

https://www.xtend.me/newsroom

and JFB’s investor relations site at

https://investors.jfbconstruction.net/

. Forward-looking statements speak only as of the date they are made and, except as may be required under applicable law, neither XTEND nor JFB undertakes any obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.

Important Information for Investors and Stockholders

This communication is for informational purposes only and is not intended to, and does not, constitute an offer to sell or the solicitation of an offer to buy any securities or a solicitation of any vote or approval, nor shall there be any issuance or sale of securities in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction. Investors and security holders of XTEND and JFB are urged to read the information statement/prospectus and registration statement on Form S-4, and any other document that has been or will be filed with the SEC in connection with the proposed transaction, carefully and in their entirety, because they contain important information. Investors and security holders will be able to obtain free copies of these documents through the website maintained by the SEC at

https://www.sec.gov

, or free of charge on JFB’s website at

https://investors.jfbconstruction.net/

.

JFB Construction Holdings Contact:

CORE IR

Mike Mason

516-222-2560


[email protected]

XTEND Media Contact:

Headline Media

Sarah Small

929-255-1449


[email protected]

XTEND Investor Relations:

MZ North America

Shannon Devine


[email protected]


203-741-8811

Source link

Hadrian Secures $360 Million Credit Facility to Expand U.S. Manufacturing Network

Opening of Hadrian’s factory in Cherokee, AL.

Hadrian has closed a $360 million revolving credit facility to finance additional manufacturing infrastructure, machinery and related hardware as the advanced manufacturing company expands production capacity for U.S. defense and aerospace customers.

The financing follows Hadrian’s recently announced $1.37 billion Series D funding round, which valued the company at $7.87 billion. Together, the equity raise and new credit facility provide additional capital for a manufacturing buildout that now spans four facilities totaling just under 3 million square feet, with more sites under development.

Morgan Stanley Senior Funding Inc. served as lead left arranger and bookrunner for the revolving facility. Western Alliance Bank, J.P. Morgan, First Citizens Bank, Customers Bank, HSBC Ventures USA Inc., Axos Bank and Texas Capital Securities also served as joint lead arrangers and bookrunners.

Hadrian plans to use the credit facility to continue investing in the physical infrastructure required to scale its manufacturing model. Unlike funding directed primarily toward software development or corporate expansion, the facility is intended to support capital-intensive assets including production equipment and factory hardware.

That capacity is central to Hadrian’s strategy of building highly automated U.S. factories that combine process engineering, artificial intelligence and robotics. The company is targeting defense and aerospace manufacturing, where scaling production requires not only factory space but also specialized machinery, production systems and repeatable processes capable of meeting customer requirements.

“This facility’s closing represents a key next step in Hadrian’s growth trajectory,” founder and CEO Chris Power said. He added that the financing will support the company’s efforts to build additional U.S. industrial capacity and create manufacturing jobs.

Hadrian currently operates two facilities in Torrance, California, along with newly launched sites in Arizona and Alabama. Its four facilities collectively cover just under 3 million square feet, and the company has additional locations in development across the country.

The geographic expansion reflects the infrastructure requirements behind Hadrian’s effort to increase domestic production for space and defense programs. Building a larger manufacturing network requires coordinating factory construction, machinery installation, automation systems and production ramp-up while maintaining consistent processes across sites.

Hadrian’s model is designed to use automation to address those execution challenges. The company combines robotics and AI with manufacturing process engineering, seeking to increase production capacity while giving workers tools to manage more automated factory workflows.

The $360 million revolving structure also provides a different source of capital from Hadrian’s Series D equity financing. A revolving credit facility can give a company access to capital as spending requirements emerge, providing flexibility as equipment purchases and factory investments progress across multiple locations.

The new financing arrives one week after Hadrian announced the $1.37 billion Series D. The company did not provide a breakdown of how the equity financing and revolving facility will be allocated among individual factories or equipment programs.

Hadrian’s expansion is focused on the manufacturing infrastructure behind defense and aerospace supply chains, where increasing output can involve significant capital spending before additional production comes online. Factory footprints must be developed and equipped, manufacturing processes validated and capacity coordinated with customer programs.

The company ultimately aims to enable space and defense manufacturers to produce complete programs at greater scale in the United States. Its growing network of factories provides the physical foundation for that strategy, while automation is intended to improve how production capacity can be deployed and replicated across facilities.

Kirkland & Ellis served as legal counsel to Hadrian on the revolving credit transaction.

With its latest debt facility and Series D financing completed in close succession, Hadrian has added substantial capital for the next stage of its U.S. factory buildout, shifting the focus toward deploying machinery, commissioning infrastructure and translating its expanded footprint into production capacity for aerospace and defense customers.

Source link

Trump Slaps Up to 100% Tariffs on Drones to Boost US Manufacturing, Citing National Security Risks

US President Donald J. Trump has signed a proclamation imposing tariffs of up to 100% on imported drones and certain drone components, citing national security risks and vulnerabilities arising from foreign dependence on critical Unmanned Aircraft System (UAS) components.

“The Proclamation imposes a 100% ad valorem tariff on drones of a certain size or with certain capabilities that are particularly sensitive for national security purposes,” the White House said. The tariff covers drones with a maximum takeoff weight of more than 25 kg, drones with thermal imaging capabilities, their docking stations and certain critical components.

The proclamation imposes a 25% ad valorem tariff on certain smaller drones that lack capabilities considered particularly sensitive to national security, as well as other drone components.

For selected trading partners, the tariff rates will be lower. Drones and components from the European Union, Japan, Liechtenstein, Republic of Korea, Switzerland and Taiwan will attract a 15% tariff, while those from the UK will face a 10% tariff, provided “substantially all hardware, software, and technology originates from within these countries and the United States.”

“The tariffs will take effect 21 days after signing,” the White House said. Tariffs on non-sensitive drone components will take effect after 180 days. Products and components approved by the Department of War for exemption from the Federal Communications Commission’s Covered List within 20 days of signing will also face tariffs after 180 days.

The proclamation authorises the Commerce Secretary to establish an onshoring programme for companies making new investments in US drone and component manufacturing.

“Drones are a key technology in modern armed conflict and critical for present and future U.S. military operations,” the White House said, adding that commercial and military drones rely on foreign sources for critical UAS components, creating “significant risks to U.S. national security and creates cybersecurity vulnerabilities.”

The administration said “U.S. drone production needs to be expanded rapidly” to strengthen national and economic security and support jobs in the country’s defence and defence-adjacent industrial base.

The latest move builds on Trump’s broader use of Section 232 tariffs to protect industries considered critical to US national security. The White House said the administration has imposed or strengthened tariffs on steel, aluminium, copper, trucks, automobiles, timber, lumber and pharmaceuticals since Trump’s return to office..

Source link

Apple opens Advanced Manufacturing Center in Houston

August 13, 2026

PRESS RELEASE

Apple opens
Advanced Manufacturing :br(s): Center :br(s): in Houston

New training center helps American workers and businesses expand smart manufacturing skills

CUPERTINO, CALIFORNIA Apple today opened its new Advanced Manufacturing Center (AMC) in Houston. The center offers free training and educational sessions for small- and medium-sized businesses, giving them direct experience with state-of-the-art equipment, interactive labs, and tools they need to accelerate innovation. The AMC is located within the same Houston facility that builds and ships Apple’s advanced AI servers and will begin manufacturing Mac mini this year.

At the center — the company’s second U.S. manufacturing learning site — experts teach participants many of the same innovative processes used to make Apple products. As part of the center’s kickoff event, Apple is proud to host U.S. Secretary of Commerce Howard Lutnick, U.S. Senator Ted Cruz, Houston Mayor John Whitmire, U.S. Representative Christian Menefee, and Harris County Precinct One Commissioner Rodney Ellis, along with other officials and community partners. They are joining Apple leaders and the AMC’s first cohort of small- and medium-sized business leaders for a full day of hands-on training and programming.

“In less than nine months, we have invested hundreds of millions of dollars into this Houston facility. We stood up a factory, started production, and shipped the first advanced AI servers off the line. Today, we’re thrilled to open our new Advanced Manufacturing Center, a place where businesses, workers, and students can learn the same innovative processes that we use to make Apple’s most groundbreaking products. And we’re pleased to begin Mac mini production later this year,” said Tim Cook, Apple’s CEO. “We believe in American workers and American ingenuity, and we are moving at an incredible pace because we want to build more than great products. We want to build the future of American manufacturing.”

“This opening is an important step in Apple delivering on its promise to bring its manufacturing back to America,” said U.S. Secretary of Commerce Howard Lutnick. “With this Advanced Manufacturing Center, Apple will equip American workers with the skills they need to lead the next generation of technology.”

Inside the 20,000-square-foot center, Apple experts will share their knowledge directly with participating businesses and entrepreneurs to help accelerate smart manufacturing across America. Curriculum topics will range from classroom sessions on advanced manufacturing principles for final assembly and design considerations for printed circuit board assembly, to interactive workshops that make use of the site’s representative production facility and equipment. As programming expands, the AMC will offer the same hands-on training to local college students, equipping the next generation of American manufacturing workers with critical skills.

To mark the AMC’s opening, its first cohort of small- and medium-sized business leaders is spending the day immersed in hands-on training led by Apple engineers, covering smart manufacturing techniques like machine-learning-driven quality control and advanced automation. Participants are learning how to identify and adapt to production challenges in real time, engage with the lab’s holographic table and advanced factory-floor equipment, and gain hands-on experience assembling and laser etching a product themselves.

The AMC builds on the work of the Apple Manufacturing Academy, which opened in Detroit in August 2025 and has already helped nearly 1,000 American companies learn smart manufacturing techniques and integrate AI into their production processes. The Apple Manufacturing Academy’s virtual programming also offers flexible, on-demand learning covering topics including automation, quality control optimization, and machine learning with vision, as well as professional development training.

Apple announced earlier this year that it will bring Mac mini production to Houston. The company shipped its first advanced AI servers less than a year after identifying a factory site. Since announcing a $600 billion commitment last year, Apple and its American Manufacturing Program partners have invested in designing and producing custom silicon, advanced components, and cover glass in the U.S., demonstrating the company’s long-standing commitment to strengthening the country’s advanced manufacturing sector.

Businesses interested in the Advanced Manufacturing Center can sign up to be notified for future sessions.

Texas Governor Greg Abbott:
“Apple’s expansion in Houston underscores Texas as the epicenter of American industry and innovation. This new facility will deliver the skills Texans need to excel in advanced manufacturing. We thank Apple for its confidence in the Lone Star State.”

U.S. Senator Ted Cruz:
“Apple’s new Advanced Manufacturing Center underscores that Texas is the best state in the country to do business. We prioritize innovation, competition, and make it easy for employers to grow and thrive. This new facility will drive job creation and directly benefit our communities by giving small- and mid-sized businesses access to cutting-edge equipment, interactive labs, and operations expertise. This project isn’t just great news for Lone Star State businesses, however. It’s great news for Texas working families.”

U.S. Representative Christian D. Menefee:
“I’m excited about the opportunity Apple is bringing to Houston — partnering with small businesses, keeping manufacturing in the U.S., and creating jobs so folks in our community can build a future right here at home. This is a good day for Houston.”

Houston Mayor John Whitmire:
“Houston is grateful to Apple for this significant investment in our city. The Advanced Manufacturing Center will create local jobs and will continue improving the quality of life of Houston residents. The AMC also recognizes our city as a growing technology hub and solidifies Houston’s leadership in the manufacturing sector of the United States.”

Harris County Precinct One Commissioner Rodney Ellis:
“I am proud that Apple chose Harris County for this investment. My office has consistently fought to bring good jobs within reach of working people and ensure small businesses — especially those historically shut out — have a fair opportunity to compete and grow. At a time when rising costs are squeezing families here and across the country, this new center can help create pathways to greater economic security. I want every young person growing up in our neighborhoods, every student at a university or community college, and every small business owner working to grow their business to know there is a place for them in the future being built here. Investments like these expand opportunity to ensure that no one is left behind.”

About Apple
Apple revolutionized personal technology with the introduction of the Macintosh in 1984. Today, Apple leads the world in innovation with iPhone, iPad, Mac, AirPods, Apple Watch, and Apple Vision Pro. Apple’s six software platforms — iOS, iPadOS, macOS, watchOS, visionOS, and tvOS — provide seamless experiences across all Apple devices and empower people with breakthrough services including the App Store, Apple Music, Apple Pay, iCloud, and Apple TV. Apple’s more than 150,000 employees are dedicated to making the best products on earth and to leaving the world better than we found it.

Press Contacts

Nick Leahy

Apple

nleahy@apple.com

Anna Mitchell

Apple

anna_m@apple.com

Apple Media Helpline

media.help@apple.com

Source link

Ford Shifts Lincoln Production Home: Strengthening U.S. Manufacturing Edge

Ford Motor Company announced plans to relocate the production of certain Lincoln models from China to the United States by the year 2030. Ford’s CEO emphasized that this decision, while challenging, is essential to fortify America’s auto manufacturing sector in light of significant import tariffs.

The primary vehicles affected, such as the Lincoln Nautilus, face a hefty U.S. import tariff of 52.5%. These tariffs, alongside restrictions from the Connected Vehicle Rule, have compelled automakers to reconsider their international production strategies. Ford’s decision reflects a wider industry trend, as evidenced by General Motors planning to move Buick Envision production stateside.

The move is part of Lincoln’s strategy to enhance its U.S. production capabilities, building on existing operations in Kentucky and Illinois. Ford’s commitment to domestic production highlights an industry shift towards mitigating regulatory risks and strengthening the U.S. manufacturing edge amid evolving trade policies.

(With inputs from agencies.)

Source link

NurExone Announces Binding MOU with Made Scientific for U.S. GMP Manufacturing and Commercial Supply Partnership

The Signed MOU Targets Initial GMP Exosome Batches in H1 2027 to Support NurExone’s Clinical Pipeline and Planned Commercial Production

TORONTO and HAIFA, Israel, Aug. 13, 2026 (GLOBE NEWSWIRE) — NurExone Biologic Inc. (“NurExone” or the “Company“) (TSXV: NRX, OTCQB: NRXBF, FSE: J90), a biotechnology company developing exosome-based regenerative therapies, today announced that its wholly owned U.S. subsidiary, Exo-Top Inc. (“Exo-Top“), together with the Company, has signed a binding memorandum of understanding (“MOU“) with Made Scientific, Inc. (“Made Scientific”) to establish an exclusive U.S. Good Manufacturing Practice (“GMP”) manufacturing and commercial exosome supply partnership to support NurExone’s clinical and commercial activities.

The proposed partnership brings together two companies with a shared vision for building scalable U.S. manufacturing infrastructure to support exosome-based therapeutics and commercial exosome products – two rapidly growing markets.

Made Scientific is a U.S.-based cell therapy contract development and manufacturing organization (“CDMO“) which operates a 60,000-square-foot U.S. FDA and EU GMP Annex 1 compliant facility in Princeton, New Jersey.

The parties intend to immediately begin the transfer of NurExone technology in parallel with negotiation of a definitive partnership agreement, with a target of initiating first GMP exosome batches in H1 2027.

Get the latest news


delivered to your inbox

Sign up for The Manila Times newsletters

By signing up with an email address, I acknowledge that I have read and agree to the Terms of Service and Privacy Policy.

“Partnering with highly regarded organizations is essential to building world-class manufacturing around novel therapeutic approaches, including exosome-based therapies,” said Dr. Lior Shaltiel, Chief Executive Officer of NurExone. “This allows us to focus on what we do best and create shareholder value, while working with specialized partners to support execution. Made Scientific is an ideal strategic partner because of its manufacturing capabilities, operational expertise, and shared long-term vision. Together, we have an opportunity to establish a U.S. manufacturing and commercialization platform to accelerate NurExone’s therapeutic pipeline, including lead candidate ExoPTEN, while creating a foundation for company revenue, commercial growth and leadership in the emerging exosome market.”

Syed T. Husain, Chairman and CEO of Made Scientific, commented, “NurExone has developed a differentiated exosome platform with significant clinical and commercial potential. This collaboration combines NurExone’s innovative bone marrow-derived exosome platform with Made Scientific’s manufacturing and regulatory expertise, creating an integrated pathway to bring exosome-based therapies from development through commercial supply.”

The proposed collaboration builds on NurExone’s broader manufacturing strategy, including bioprocess optimization with Novasign GmbH announced on July 30, 2026. Together, these initiatives are intended to strengthen the infrastructure supporting both NurExone’s therapeutic pipeline and future commercial exosome activities, positioning the Company for long-term, sustainable commercial success.

Under the binding MOU, Made Scientific will serve as NurExone’s exclusive U.S. partner for the manufacturing and aseptic fill-finish of NurExone’s bone marrow-derived exosomes. The MOU contemplates that the definitive agreement, if executed, will feature an initial term of five (5) years, with options for successive five-year renewals. If the parties do not execute a definitive agreement within six months of MOU execution, the MOU and ongoing obligations, including exclusivity grants, will automatically terminate, subject to specified surviving obligations.

Update Regarding BioXtek Letter of Intent

The Company also announced that Exo-Top has mutually agreed with Florida-based BioXtek Inc. (“BioXtek”) not to proceed with the non-binding Letter of Intent (“LOI“) previously announced on April 7, 2026. This decision follows NurExone’s strategic pivot to consolidate its U.S. GMP exosome manufacturing infrastructure under the proposed collaboration with Made Scientific. NurExone and BioXtek intend to explore potential collaborative business opportunities outside of direct production in the near future.

About Made Scientific

Made Scientific is a leading U.S.-based cell therapy contract development and manufacturing organization (CDMO) specializing in the development, manufacturing, and release of autologous and allogeneic cell therapy products for clinical- and commercial-supply. Headquartered in Princeton, New Jersey, Made Scientific combines the agility of a specialist CDMO with the deep technical expertise to deliver reliable and scalable solutions, supported by their long-term strategic backer, GC Corporation, a global leader in the pharmaceutical and biotechnology sectors. For more information, visit www.madescientific.com.

About NurExone

NurExone is a TSX Venture Exchange (“TSXV”), OTCQB, and Frankfurt-listed biotech company focused on developing regenerative exosome-based therapies for central nervous system injuries. Its lead product, ExoPTEN, has demonstrated strong preclinical data supporting clinical potential in treating acute spinal cord and optic nerve damage. Regulatory milestones, including obtaining the Orphan Drug Designation, support the Company’s roadmap towards clinical trials in the U.S. and Europe. Commercially, the Company intends to offer solutions to companies interested in quality exosomes and minimally invasive targeted delivery systems for other indications. NurExone has established Exo-Top to anchor its North American activity and growth strategy.

For additional information and a brief interview, please watch Who is NurExone?, visit www.nurexone.com or follow NurExone on LinkedIn, Twitter, Facebook, or YouTube.

For more information, please contact:

Dr. Lior Shaltiel

Chief Executive Officer and Director

Phone: +972-52-4803034

Email: [email protected]

Russo Partners LLC

Investor and Media Relations – United States

215 Park Ave S, Suite 1905

New York, NY 10003

Phone: 212-845-4200

Email: [email protected]

Dr. Eva Reuter

Investor Relations – Germany

Phone: +49-69-1532-5857

Email: [email protected]

FORWARD-LOOKING STATEMENTS

This press release contains “forward-looking information” and “forward-looking statements” within the meaning of applicable Canadian securities laws (collectively, “forward-looking statements”). Forward-looking statements are often, but not always, identified by words such as “may”, “will”, “should”, “could”, “expect”, “plan”, “intend”, “anticipate”, “believe”, “estimate”, “potential”, “target”, “designed to”, “goal”, “subject to”, “contemplate” and similar expressions, or statements that events, conditions or results “may”, “could”, “would”, “should” or “will” occur or be achieved.

Forward-looking statements in this press release include, without limitation, statements relating to: the proposed collaboration with Made Scientific; the negotiation, execution, timing and terms of any definitive agreement; the expected scope, objectives and potential benefits of the MOU and proposed definitive agreement; the technology transfer, process establishment, manufacturing, aseptic fill-finish, quality, regulatory, commercial supply and distribution activities contemplated by the MOU; the target timing for initiating first GMP exosome batches; the ability of the parties to complete due diligence, approve SOWs, enter into definitive documentation, satisfy applicable technical, quality, regulatory, commercial, securities law and stock exchange requirements, and operationalize the proposed collaboration; the potential role of Made Scientific as a U.S. manufacturing partner; the potential use of the proposed collaboration to support NurExone’s clinical pipeline, Exo-Top activities, potential future commercial exosome activities and broader manufacturing strategy; the expected relationship between the proposed collaboration, Exo-Top and the Company’s previously announced bioprocess optimization initiative with Novasign; the potential commercialization of exosome products in jurisdictions where legally permitted; the potential exploration of business opportunities with BioXtek outside of direct production; and the Company’s development, regulatory, manufacturing, commercialization and platform opportunities.

Forward-looking statements are based on management’s current expectations and assumptions as of the date of this press release, including assumptions regarding: the ability of NurExone, Exo-Top and Made Scientific to proceed with the MOU and negotiate and enter into a definitive agreement on acceptable terms, or at all; the successful completion of due diligence; the approval and performance of applicable SOWs; the continued willingness and ability of each party to proceed with the proposed collaboration; the availability of required personnel, capital, materials, equipment, manufacturing capacity, cleanroom availability, quality systems, technical information and third-party services on commercially reasonable terms; the ability to complete technology transfer, process establishment, scale-up, quality-control and release activities; the continued accuracy and relevance of the Company’s manufacturing, scientific, regulatory and commercial plans; the ability to satisfy applicable regulatory, securities law, stock exchange and commercial requirements; the ability to maintain required intellectual property, confidentiality and regulatory protections; and the absence of material adverse technical, regulatory, commercial, legal, market, financing or operational developments.

Forward-looking statements are subject to known and unknown risks, uncertainties and other factors that may cause actual results, performance or achievements to differ materially, including, without limitation: the risk that a definitive agreement with Made Scientific may not be entered into on the timeline contemplated or at all; the risk that the MOU may terminate if a definitive agreement is not executed within the six-month period contemplated by the MOU; the risk that the proposed collaboration may not proceed as currently contemplated or may be terminated, delayed or restructured; due diligence, negotiation, documentation, SOW approval and approval risks; technology transfer, manufacturing scale-up, process development, quality-control, batch release, supply chain, raw material, equipment, facility, cleanroom availability, storage, logistics and cost risks; regulatory review, clinical development and commercialization risks; the risk that products may not be approved, authorized, commercially viable or legally marketable in one or more jurisdictions; the risk that anticipated manufacturing capacity, timelines, cost efficiencies, batch timing, commercial supply arrangements or revenue opportunities may not be achieved; risks related to exclusive arrangements, rights of first refusal or rights of first offer; dependence on third-party collaborators, manufacturers, suppliers, distributors and service providers; risks related to intellectual property, confidential information, data, know-how and regulatory documentation; financing and market risks; competition and technological change; general biotechnology and early-stage development risks; the risk that preclinical results may not be predictive of clinical results; and the risks described in the Company’s continuous disclosure filings available under its profile on SEDAR+, including the risks described under the heading “Risk Factors” in the Company’s annual information form and other public disclosure documents.

Readers are cautioned not to place undue reliance on forward-looking statements. Although the Company believes that the assumptions underlying the forward-looking statements are reasonable, forward-looking statements are not guarantees of future performance, and actual results may differ materially from those expressed or implied by such statements. Forward-looking statements are made as of the date of this press release, and the Company undertakes no obligation to update or revise any forward-looking statements, except as required by applicable law.

Neither the TSXV nor its Regulation Services Provider, as that term is defined in the policies of the TSXV, accepts responsibility for the adequacy or accuracy of this release.

Source link

Stanley Black & Decker Investing $1 Billion in the U.S. to Drive Innovation, Strengthen U.S. Manufacturing Footprint and Expand the Skilled Trades Workforce Essential to Building America’s Infrastructure

NEW BRITAIN, Conn., Aug. 12, 2026 /PRNewswire/ — As U.S. infrastructure investment accelerates, the construction sector faces a critical challenge: deploying cutting-edge tools and technologies to boost productivity while closing a widening skilled trades gap, with nearly half a million new workers needed by 2027. Against this backdrop, Stanley Black & Decker (NYSE: SWK) is investing $1 billion in the U.S. to advance innovation, develop next-generation tools and solutions, and increase access to training opportunities to expand the skilled trades workforce.

“Our U.S. investment strategy has multiple dimensions and goes far beyond expanding manufacturing – it’s about igniting innovation, building world-class capabilities, and redefining the future of work in America,” said Chris Nelson, Stanley Black & Decker’s President and Chief Executive Officer. “By leaning into research and development and investing in the future of our U.S. operations, we are setting the benchmark for next-generation products and solutions. These investments will empower America’s tradespeople to work safer, reach new levels of productivity, and rise to help solve the nation’s toughest challenges. This is how we plan to lead America forward – by building, competing, and innovating.”

Of the $1 billion Stanley Black & Decker plans to invest through 2028, approximately 50% will go to research and development to accelerate the creation of next-generation tools and breakthrough solutions for trades professionals. The other 50% will support capital expenditures and long-term investments to further strengthen its U.S. manufacturing footprint and support new product development. In addition, Stanley Black & Decker has committed to investing $60 million through its DEWALT Grow the Trades initiative through 2030 – of which $27 million has already been deployed – to expand training programs and open new pathways to rewarding careers in the skilled trades.

“By advancing technology, investing in U.S. manufacturing and expanding training to skilled trades Stanley Black & Decker is helping to build a stronger workforce and a more resilient future for communities across the nation,” said Nelson.

Jay Timmons, President and CEO of the National Association of Manufacturers, underscored the far-reaching impact of Stanley Black & Decker’s investment in the United States. “For more than 180 years, Stanley Black & Decker has helped define what it means to make things in America – innovating, investing and creating opportunities for manufacturing workers and the communities they serve. Their commitment to strengthening U.S. manufacturing and empowering America’s manufacturers exemplifies the leadership our nation needs. These investments not only reinforce our industrial foundation – they open doors to new economic opportunities and secure a brighter future for communities across the country. This is the kind of vision that propels our industry forward.”

About Stanley Black & Decker
Founded in 1843 and headquartered in the USA, Stanley Black & Decker (NYSE: SWK) is a worldwide leader in Tools and Outdoor, operating manufacturing facilities globally. The Company’s approximately 41,000 employees produce innovative end-user inspired power tools, hand tools, storage, digital jobsite solutions, outdoor and lifestyle products, and engineered fasteners to support the world’s builders, tradespeople and DIYers. The Company’s world class portfolio of trusted brands includes DEWALT®, CRAFTSMAN®, STANLEY®, BLACK+DECKER®, and Cub Cadet®. To learn more visit: www.stanleyblackanddecker.com or follow Stanley Black & Decker on Facebook, Instagram, LinkedIn and X.

Cautionary Note Regarding Forward-Looking Statements

Forward-looking statements, within the meaning of Section 27A of the Securities Act and Section 21E of the Securities Exchange Act of 1934, as amended, are made in this press release, including statements concerning Stanley Black & Decker’s investment, innovation and philanthropy initiatives and anticipated benefits from such initiatives. These forward-looking statements are sometimes identified from the use of forward-looking words such as “believe,” “should,” “could,” “potential,” “continue,” “expect,” “project,” “estimate,” “predict,” “anticipate,” “aim,” “intend,” “plan,” “forecast,” “target,” “is likely,” “will,” “can,” “may” or “would” or the negative of these terms or similar expressions elsewhere in this press release. All forward-looking statements are subject to a number of important factors, risks, uncertainties and assumptions that could cause actual results to differ materially from those described in any forward-looking statements. These factors and risks include, but are not limited to, Stanley Black & Decker’s ability to successfully implement its investment strategy, macroeconomic and geopolitical conditions and other financial, operational and legal risks and uncertainties detailed from time to time in the Company’s risk factors and cautionary statements contained in its filings with the Securities and Exchange Commission. These forward-looking statements represent the Company’s expectations as of the date of this press release. The Company disclaims, however, any intent or obligation to update these forward-looking statements.

SOURCE Stanley Black & Decker, Inc.

Source link

Bristol Myers Squibb’s US$2.3bn Texas Manufacturing Campus

“Our decision to build this state-of-the-art manufacturing campus in Houston, Texas, reflects our confidence in the region’s ability to support a world-class, digitally advanced supply operation,” says Karin Shanahan, EVP, Chief Supply Chain and Operations Officer of BMS. 

“This facility is designed to deliver the speed, quality and reliability that patients depend on, combining flexible, modular manufacturing with advanced digital capabilities to ensure consistent supply across multiple modalities.

“It strengthens our ability to operate with resilience and positions us to reliably deliver medicines to patients today while adapting to future demands.” 

Significant investment in infrastructure

BMS has announced significant investment in its medicine development infrastructure in recent months.

Chief among these was scaling its NVIDIA-powered AI infrastructure to create the “most powerful AI factory in life sciences”.

Despite already possessing one of the industry’s most powerful AI systems, its next-gen system will deliver up to ten times greater performance per megawatt than its predecessor. 

Also set for completion in 2026 is the company’s US$400m Sterile Drug Product facility at Cruiserath Campus in Dublin.

The investment will support manufacturing and supply of existing medicines and create 350 new jobs.

Source link